A. Stefani

Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia

M. G. Marciani, G. Bernardi, P. Stanzione, 2004, Clinical Neurophysiology.

Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease.

N. Mercuri, A. Orlacchio, M. Pierantozzi, 2013, Functional neurology.

May a suspicious psychiatric disorder hide sporadic hemiplegic migraine? Genetic test as prompting factor for diagnosis

M. Marciani, G. Sancesario, M. Pierantozzi, 2013, Neurological Sciences.

Author Index Ablorh-Odjidja C: See Bass DM

C. Caltagirone, G. Spalletta, S. Dedhiya, 2012 .

Reversal of Cognitive Decline: 100 Patients

D. Bredesen, A. Stefani, David Jenkins, 2018 .

Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy

A. Stefani, S. Kapoor, S. Hausman-Cohen, 2022, Frontiers in Aging Neuroscience.

Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study

P. Rossini, P. Stanzione, A. Stefani, 2002, Clinical Neurophysiology.

The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients

P. Rossini, G. Bernardi, P. Stanzione, 1999, Clinical Neurophysiology.